Concentrations of free thyroxin and free triiodothyronine in serum of patients with thyroxin- and triiodothyronine-binding autoantibodies.
Between 1982 and 1989 we identified 47 subjects with spuriously increased concentrations of free thyroxin (FT4) or free triiodothyronine (FT3) related to autoantibody interference in analog FT4 and (or) FT3 methods. The incidence of autoantibody interference observed during one year (1988) was 1 in 2460. In the subjects identified, 51% and 11%, respectively, showed an increased binding of radiolabeled T4 or T3 analog alone; 38% had an increased binding of both. Of 36 patients tested, 71% had autoantibodies to thyroglobulin and microsomal fraction of the thyroid, 19% to microsomal fraction alone, and 9.5% to thyroglobulin alone. In eight subjects, spuriously increased FT4 concentrations were reported with the following FT4 methods (in decreasing order of interference): Coat-A-Count, Amerlex-M, Amerlite, Seria, Magic Lite, Amerlex-MAB. In the same eight subjects, Amerlex-M and Seria reported spuriously increased concentrations of FT3.
John
R
R
Department of Medical Biochemistry, University Hospital of Wales, Heath Park, Cardiff, U.K.
Henley
R
R
Shankland
D
D
D000293:Adolescent; D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D008297:Male; D008861:Microsomes / Q000276:immunology; D008875:Middle Aged; D011933:Reagent Kits, Diagnostic; D013954:Thyroglobulin / Q000276:immunology; D013959:Thyroid Diseases / Q000097:blood / Q000276:immunology; D013961:Thyroid Gland / Q000648:ultrastructure; D013974:Thyroxine / Q000097:blood* / Q000276:immunology; D014284:Triiodothyronine / Q000097:blood* / Q000276:immunology
D001323:Autoantibodies; D011933:Reagent Kits, Diagnostic; D014284:Triiodothyronine; D013954:Thyroglobulin; D013974:Thyroxine